Marine Drugs · 2021 · 14 citations · 21 references
MedicineBiochemistryPharmacologyCell SignalingHemostasisSignal TransductionHemostatic AgentsInflammatory SignalingPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAdenosine Diphosphate-induced Platelet AggregationAntiplatelet Drug MechanismsAntiplatelet DrugsBleedingPi3k-akt Signaling PathwayPlatelet Function ModulationThrombin-induced Platelet AggregationThrombosis Mechanisms
Isaridin E, a cyclodepsipeptide isolated from the marine-derived fungus Amphichorda felina (syn. Beauveria felina) SYSU-MS7908, has been demonstrated to possess anti-inflammatory and insecticidal activities. Here, we first found that isaridin E concentration-dependently inhibited ADP-induced platelet aggregation, activation, and secretion in vitro, but did not affect collagen- or thrombin-induced platelet aggregation. Furthermore, isaridin E dose-dependently reduced thrombosis formation in an FeCl3-induced mouse carotid model without increasing the bleeding time. Mechanistically, isaridin E significantly decreased the ADP-mediated phosphorylation of PI3K and Akt. In conclusion, these results suggest that isaridin E exerts potent antithrombotic effects in vivo without increasing the risk of bleeding, which may be due to its important role in inhibiting ADP-induced platelet activation, secretion and aggregation via the PI3K/Akt pathways.
21
Sven Nylander, Bengt Kull, Jan‐Arne Björkman et al. · Journal of Thrombosis and Haemostasis · 2012 · 122 citations · Full text
Medicine, Cell Biology, Pharmacology +17